CD4 News and Research

RSS
Pfizer/BioNTech COVID-19 vaccine elicits both neutralizing antibodies and T cell response

Pfizer/BioNTech COVID-19 vaccine elicits both neutralizing antibodies and T cell response

Groundbreaking technology could enhance therapeutic efficiency of nanomedicines

Groundbreaking technology could enhance therapeutic efficiency of nanomedicines

New immune profiles could help predict disease trajectory in severe COVID-19 patients

New immune profiles could help predict disease trajectory in severe COVID-19 patients

Moderna vaccine induces robust immune response against SARS-CoV-2

Moderna vaccine induces robust immune response against SARS-CoV-2

A new measles-based COVID-19 vaccine

A new measles-based COVID-19 vaccine

Altimmune announces positive preclinical results of intranasal COVID-19 vaccine candidate

Altimmune announces positive preclinical results of intranasal COVID-19 vaccine candidate

Dysfunctional T cells present at high levels in severe COVID-19

Dysfunctional T cells present at high levels in severe COVID-19

Faulty immune response to SARS-CoV-2 one of the main causes of death

Faulty immune response to SARS-CoV-2 one of the main causes of death

Researchers find possible cause for SARS-CoV-2 reactive T cells in uninfected individuals

Researchers find possible cause for SARS-CoV-2 reactive T cells in uninfected individuals

Novavax SARS-CoV-2 vaccine candidate shows promise in animal models

Novavax SARS-CoV-2 vaccine candidate shows promise in animal models

Important new findings on T cell immunity in COVID-19

Important new findings on T cell immunity in COVID-19

Novel vaccine that removes aged immune cells mitigates metabolic disorders in obese mice

Novel vaccine that removes aged immune cells mitigates metabolic disorders in obese mice

Modified Vaccinia Ankara-based vaccine candidate for SARS-CoV-2

Modified Vaccinia Ankara-based vaccine candidate for SARS-CoV-2

COVID-19 patients can rapidly generate virus-attacking T cells, shows study

COVID-19 patients can rapidly generate virus-attacking T cells, shows study

Dysregulated inflammation in severe COVID-19

Dysregulated inflammation in severe COVID-19

Immune response variations across the COVID-19 spectrum

Immune response variations across the COVID-19 spectrum

Exposure to SARS-CoV-2 can induce virus-specific T cell responses without seroconversion

Exposure to SARS-CoV-2 can induce virus-specific T cell responses without seroconversion

SARS-CoV-2 induces broad T cell response in recovering patients

SARS-CoV-2 induces broad T cell response in recovering patients

Growth, adaptation and neutralization of SARS-CoV-2 with acute-phase serum

Growth, adaptation and neutralization of SARS-CoV-2 with acute-phase serum

Reassuring news on the Oxford vaccine (AZD1222) against SARS-CoV-2

Reassuring news on the Oxford vaccine (AZD1222) against SARS-CoV-2